Keywords: mgi/supergen, dacogen, filed, eu, supergen, submitted, marketing

MGI/SuperGen's Dacogen filed in EU

Article | 11 October 2004

Print This

SuperGen has submitted a Marketing Authorization Application to the European Medicines Agency for use of Dacogen (decitabine) as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in